Testing a new mitral valve replacement for high-risk patients
Part of Heart & circulation clinical trials.
This study checks whether an innovative device can safely replace a damaged mitral valve in people who are higher risk for open-heart surgery. It looks at how well the procedure and follow-up work for improving mitral leakage symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older
- You have moderate-to-severe or severe mitral valve leakage (at least 3+)
- Your heart symptoms are class II, III, or you can walk but have class IV symptoms
- You’ve been on the recommended heart medicines for at least one month
- A heart team says you’re high-risk for open-heart surgery and you match the valve’s body-size/shape needs
- A detailed heart ultrasound test (TEE) can be safely done for you
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a newer, catheter-based mitral valve treatment in people with moderate-severe to severe mitral valve leaking who are at high risk for open-heart surgery. It may help improve symptoms and heart function without traditional surgery, but you must meet key heart, anatomy, and safety requirements.
This trial studies a new catheter-based valve replacement system for people with moderate to severe, or severe, mitral valve regurgitation (a leaky mitral valve). It aims to check whether the procedure is safe and can improve heart function compared with expected care.
This study tests a new device that replaces a leaking mitral valve without open-heart surgery. It may help people who have severe mitral valve leakage but cannot safely have standard surgery or some other less invasive valve repairs.
This trial tests a new, less invasive device called the AltaValve to treat a leaky mitral valve. It is for people whose leak is severe enough to cause symptoms, but who cannot have standard surgery or a clip procedure.
This study tests a new catheter-based system to treat severe mitral valve leaking when open-heart surgery is considered high risk. It may help improve blood flow and symptoms by repairing the valve without open surgery, using ultrasound guidance and follow-up visits to track safety and results.
This trial tests a new way to replace the mitral valve using a soft tube (catheter) inserted through the leg, for people with severe leaky mitral valve who are not candidates for traditional surgery or clip repair. It aims to see how well this valve works in real-world patients across Europe.
Hear when a new Mitral Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.